ClinicalTrials.Veeva

Menu

Promise Women Project

M

Mark Dignan, PhD

Status

Completed

Conditions

Human Papilloma Virus
Cervical Cancer

Treatments

Behavioral: Promise women project (Promote Cervical Cancer Prevention Methods Among Muslim Women in Virginia )

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05862844
3P30CA177558-10S1 (U.S. NIH Grant/Contract)
HM20024502_VCU

Details and patient eligibility

About

The goal of this study is to develop and test an intervention program to improve cervical cancer prevention among Muslim American women. The main questions the investigators aim to answer are:

  • Will the religiously tailored and culturally appropriate intervention program improve participants' knowledge and acceptance of cervical cancer prevention?
  • Is the intervention program feasible to conduct and acceptable to participants?

Participants will be asked to:

  • Attend focus group sessions to provide input on the development of educational materials.
  • Complete pre- and post-intervention surveys to measure changes in knowledge and acceptance of cervical cancer prevention.
  • Engage in the intervention program, which includes education and experiential practice/communication skills training.
  • Provide feedback through satisfaction surveys. Researchers will compare participant outcomes before and after the intervention to assess its effectiveness. Additionally, the program's feasibility and acceptability will be evaluated based on enrollment rates, successful implementation, participant engagement, retention, and satisfaction.

Full description

This project involves creating special educational materials for Muslim women to learn about cervical cancer prevention. The investigators will engage in discussions with 10 Muslim women during dedicated group sessions to ensure the suitability of the materials. They will also seek input from Muslim religious leaders. Subsequently, they will conduct surveys before and after the program to assess the effectiveness of the materials in facilitating women's learning and comprehension of cervical cancer prevention. To determine its efficacy and acceptability, the investigators will implement the program with an additional 20 women and gather their feedback. The goal of this project is to promote the health and well-being of Muslim women by providing them with culturally and religiously sensitive information regarding cervical cancer prevention.

Enrollment

20 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Inclusion criteria:
  • Female Muslim individuals above 18 years old.
  • Able to speak and understand English.
  • Have not had a hysterectomy.
  • Have not had a cervical cancer diagnosis.
  • Willing to participate in the educational program and undergo cervical cancer screening.
  • Physically well, able to give consent form.

Exclusion criteria

  • Under age 18
  • Not Muslim
  • Unable to provide consent
  • Participated in a pilot study

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

The single-arm trial with a pre- and post-test design
Experimental group
Description:
The Intervention Arm in the Promise Women Project evaluates a specific educational intervention program for Muslim women to promote cervical cancer prevention. It involves a one-time, 90-minute culturally and religiously tailored educational session with 20 participants. The session covers perceived risks of Human Papilloma Virus (HPV) infection, cervical cancer, and benefits of early screening and vaccination. Pre- and post-intervention surveys measure changes in participants' knowledge. This experimental arm assesses the intervention's effects on knowledge and acceptance of cervical cancer prevention.
Treatment:
Behavioral: Promise women project (Promote Cervical Cancer Prevention Methods Among Muslim Women in Virginia )

Trial documents
2

Trial contacts and locations

4

Loading...

Central trial contact

Asmaa Namoos, MD, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems